| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/1992 | CN1061594A Hydroxyalkylquineline ether acids as leakotaiene antagonists |
| 06/03/1992 | CN1061528A Process for preparing pharmaceutical containing dihydripyrodine laetol compounds |
| 06/03/1992 | CN1061527A Quickly effective atomized agent and sprayer for curing a cold and the preparation method thereof |
| 06/03/1992 | CN1016872B Bcd tricyclic ergoline part-structure analoguse |
| 06/03/1992 | CN1016871B Process for the preparation of tricyclische pyridinderivate and their use |
| 06/03/1992 | CN1016869B Process for preparing 6, 7-diacyl-7-deacetyl forskolin derivatives |
| 06/03/1992 | CN1016868B 5-arylalkyl-4-alkoxy-2(5h)-furanones, process and intermediates for preparing thereof and use as pharmaceutical compositions |
| 06/02/1992 | USRE33948 Bactericides, animal growth regulators |
| 06/02/1992 | US5118882 Streptenols from streptomycetes, and the preparation and use thereof |
| 06/02/1992 | US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases |
| 06/02/1992 | US5118714 Aqueous extract from pittosporaceae effective for treating diabetes and liver dysfunction |
| 06/02/1992 | US5118709 Arylhydrazones and pharmaceutical compositions containing the same |
| 06/02/1992 | US5118708 Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents |
| 06/02/1992 | US5118707 Compositions for regulating skin wrinkles comprising a benzofuran derivative |
| 06/02/1992 | US5118705 Water soluble salts of purpuromycin and pharmaceutical formulations thereof |
| 06/02/1992 | US5118703 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 06/02/1992 | US5118701 Antiischemic agents, anticoagulants |
| 06/02/1992 | US5118700 Indole derivatives and compositions for their use in medicaments |
| 06/02/1992 | US5118698 Pharmaceutical preparations |
| 06/02/1992 | US5118694 Benzopyran derivatives |
| 06/02/1992 | US5118693 4,4-disubstituted piperidine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/02/1992 | US5118690 Pharmaceutical tetrahydroisoquinolines |
| 06/02/1992 | US5118689 Antiarrhythmia agents |
| 06/02/1992 | US5118688 Tetrahydropyridoquinolone derivatives useful as anxiolytic agents |
| 06/02/1992 | US5118687 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/02/1992 | US5118686 Phenylpyrimidones |
| 06/02/1992 | US5118685 Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, and therapeutic agents containing these compounds |
| 06/02/1992 | US5118684 Piperdine derivative and pharmaceutical composition |
| 06/02/1992 | US5118682 P-hydroxy phenone derivatives and the use thereof |
| 06/02/1992 | US5118680 Combating endoparasites with 3-hydroxybenzothiophenes |
| 06/02/1992 | US5118679 Agent for preventing and treating opacity of lens |
| 06/02/1992 | US5118677 For treating transplant rejection, host vs. draft disease, autoimmune diseases and inflammations; antibody inhibitors |
| 06/02/1992 | US5118674 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them |
| 06/02/1992 | US5118673 Uses of aloe products |
| 06/02/1992 | US5118671 Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them |
| 06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 06/02/1992 | US5118624 Method for the stimulation of cell growth and the inhibition of cell proliferation by the utilization of selenodithiols such as selenodiglutathione |
| 06/02/1992 | US5118510 Niacin drink mix formulation |
| 06/02/1992 | US5118509 Inducing skin tolerance to a sensitizing drug |
| 06/02/1992 | US5118508 Pharmaceutical composition |
| 06/02/1992 | US5118505 Ginkge extract and folic, lipoic and(or) vitamin b |
| 06/02/1992 | US5118500 Side effect reduction when administering a xanthine derivative |
| 06/02/1992 | US5118493 Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine |
| 06/02/1992 | US5117830 Method of determining viability of tissue |
| 06/02/1992 | CA1302432C Process for the preparation of 5-hydroxydiprafenone and its acid addition salts |
| 06/02/1992 | CA1302425C Prodrugs of antihypercholesterolemic compounds |
| 06/02/1992 | CA1302424C Phenolic thioethers as inhibitors of 5-lipoxygenase |
| 06/02/1992 | CA1302421C 3-aryloxy-3-substituted propanamines |
| 06/02/1992 | CA1302418C 3,5-disubstituted pyrocatechole derivatives |
| 06/02/1992 | CA1302417C 2-substituted-1-naphthols as 5-lipoxygenase inhibitors |
| 06/02/1992 | CA1302416C Platinum triamine antitumor agents |
| 06/02/1992 | CA1302415C 1-hydroxy-2-pyridones, a process for their preparation, and medicaments which contain them, and intermediates formed in the preparation of the 1-hydroxy-2-pyridones |
| 06/02/1992 | CA1302412C 5-chloro-s-triazolo[4,3-a]pyridine-7-carboxylic acids |
| 06/02/1992 | CA1302411C2 5,6-dihydro-2-(substituted phenyl)-1,2-4-triazine-3,5-(2h,4h)-diones |
| 06/02/1992 | CA1302410C Dihydropyridine anti-allergic and anti-inflammatory agents |
| 06/02/1992 | CA1302409C Benzazepine derivatives |
| 06/02/1992 | CA1302407C Process for the preparation of macrolide compounds |
| 06/02/1992 | CA1302406C Method of manufacturing moranoline derivatives |
| 06/02/1992 | CA1302405C Ergoline derivatives |
| 06/02/1992 | CA1302404C .alpha.-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
| 06/02/1992 | CA1302403C Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
| 06/02/1992 | CA1302402C Compounds |
| 06/02/1992 | CA1302281C Antiallergic agent containing isoliquiritigenin |
| 06/02/1992 | CA1302280C Topical antimicrobial pharmaceutical compositions and methods |
| 06/02/1992 | CA1302279C Solid dispersion composition of fr-900506 substance |
| 06/02/1992 | CA1302278C Injection solutions of torasemide which are ready to use and processes for their preparation thereof |
| 06/02/1992 | CA1302277C Treatment of androgenic alopecia with 17beta-n- mono-substituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones |
| 06/02/1992 | CA1302276C Treatment of prostatic carcinoma with 17beta-n-mono- substituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones |
| 06/02/1992 | CA1302275C Enzyme inhibitor |
| 06/02/1992 | CA1302274C Antibacterial drugs for fish |
| 06/02/1992 | CA1302273C Pyrimidine derivatives for treatment of rheumatoid arthritis |
| 06/02/1992 | CA1302272C Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and theiruse in treating clot formation |
| 06/02/1992 | CA1302271C Method of promoting wound-healing |
| 06/02/1992 | CA1302270C Carcinostatic agent |
| 06/02/1992 | CA1302269C Penetrating topical pharmaceutical compositions |
| 06/02/1992 | CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor |
| 06/02/1992 | CA1302267C Oral therapeutic system having systemic action |
| 06/02/1992 | CA1302266C Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems |
| 06/02/1992 | CA1302265C Glucuronic acid derivatives of opioid antagonists |
| 06/02/1992 | CA1302262C Pharmaceutical composition containing flutiasone propionate |
| 06/02/1992 | CA1302253C Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| 05/31/1992 | WO1992009276A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
| 05/31/1992 | CA2095334A1 Pharmaceutical compositions |
| 05/31/1992 | CA2056800A1 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 05/31/1992 | CA2056723A1 Use of xanthines for the preparation of a medicament having immuno supressing activity |
| 05/31/1992 | CA2056693A1 Compounds |
| 05/31/1992 | CA2056657A1 Pharmaceutical formulations containing a mixture of higher primary aliphatic alcohols in the treatment of hypercholesterolaemia and hyperlypoproteinaemia type ii and stimulation of sexual behaviour in animals and humans |
| 05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 05/30/1992 | WO1992009280A1 Use of pyridine derivatives in the treatment of ocular hypertension |
| 05/30/1992 | CA2096012A1 Intraocular pressure lowering heterocyclic compounds |
| 05/30/1992 | CA2056560A1 Guanidine derivates, the process for the preparation thereof and the pharmaceutical compositions containing them |
| 05/30/1992 | CA2056032A1 Hard capsule preparation |
| 05/30/1992 | CA2055308A1 Imidazobenzodiazepine for the treatment of sleep disorders |
| 05/30/1992 | CA2036587A1 Antiulcer substance |
| 05/29/1992 | WO1992009582A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| 05/29/1992 | WO1992009252A1 Method and device for treating tobacco addiction |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008730A1 Novel steroidal organic substance crystallization method and compounds thereby obtained |
| 05/29/1992 | WO1992008721A1 Novel cephalosporin compounds and processes for preparation thereof |
| 05/29/1992 | WO1992008717A1 Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |